Meeting
2023 ASCO Annual Meeting
Spectrum of germline pathogenic variants among patients with cancer in Mexico.
Authors
Jose Luis Rodriguez Olivares
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, Mexico
Jose Luis Rodriguez Olivares , Maria Teresa Bourlon De Los Rios , Hector De la Mora Molina , Jazmin Arteaga Vazquez , Andrea Morales Alfaro , Araceli Carrillo Bedoya , Gregorio Quintero Beulo , Sánchez Reyes Roberto Iván , Danielle Castillo , Josef Herzog , Jeffrey N. Weitzel , Yanin Chavarri Guerra
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10620)
DOI
10.1200/JCO.2023.41.16_suppl.10620
Abstract #
10620
Poster Bd #
253
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Tumor sequencing with germline genetic testing: Identification of patients with hereditary cancer and precision treatment eligibility.
First Author: Scott T. Michalski
Poster
2019 ASCO Annual Meeting
Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative.
First Author: Allison W. Kurian
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos
Poster
2017 ASCO Annual Meeting
Performance of mutation risk prediction models in a racially diverse multi-gene panel testing cohort.
First Author: Gregory Idos